Schott Pharmaceutical Packaging has revealed details of its US-based ready-to-fill syringe production line capabilities in a manufacturing sector that has traditionally been the strong hold of countries like Germany and France.
Demand for Cerep’s pharmacological profiling services picked up in the second quarter and it believes this, coupled to cost savings and commencement of delayed contracts, will help it improve in the second half of 2009.
Jubilant Organosys, India's largest custom research and manufacturing services (CRAMS) provider, has reorganised its business in North America in the wake of its recent acquisitions of HollisterStier Laboratories and Draxis Specialty Pharmaceuticals.
Jubilant Organosys moved another step closer to completing its
purchase of contract research and manufacturing services (CRAMS)
company Draxis Health, after shareholders gave their blessing to
the transaction in a vote last Friday.